Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Withings announces hands-free connected in-home urine lab

January 6, 2023 Medical Communications

Connected health firm Withings has unveiled its new in-home biomarker analysis platform U-Scan. It is hoped the device will utilise …
News

Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs

January 5, 2023 Medical Communications

AMSTERDAM, THE NETHERLANDS, 5 January 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for …
News
Press release

FDA accepts application for nirsevimab as first protective option for RSV in infants

January 5, 2023 Medical Communications

The FDA has accepted an application for nirsevimab as the first protective option to combat respiratory syncytial virus (RSV) disease …
News

FDA expands access to abortion pills

January 4, 2023 Medical Communications

Following new rules from the FDA under the Biden administration, patients can now obtain the abortion pill mifepristone from retail …
News

Novartis pays $245m to settle Exforge generic pay-for-delay lawsuit

January 4, 2023 Medical Communications

Swiss pharma company Novartis will settle a classic generic pay-for-delay legal battle with direct purchasers, indirect purchasers and retailers regarding …
News

FDA grants Breakthrough Device Designation for Burning Rock’s multi-cancer detecting test

January 4, 2023 Medical Communications

Burning Rock, a Chinese biotech company which focuses on the applications of next-generation sequencing (NGS) technology in the field of …
News

FDA expected to make decision on controversial Alzheimer’s drug this week

January 4, 2023 Medical Communications

The FDA are expected to come to a decision on Eisai and Biogen’s Alzheimer’s drug lecanemab by the end of …
News

MediWound receives FDA approval for NexoBrid

January 3, 2023 Medical Communications

Israeli biopharma company MediWound has secured FDA approval for its wound care product NexoBrid (anacaulase-bcdb). US-based biopharma company Vericel will …
News

Datar blood test receives FDA Breakthrough Designation

January 3, 2023 Medical Communications

Datar Cancer Genetics has secured FDA Breakthrough Designation for their blood test used to detect inaccessible brain tumours, where traditional …
News

BioNTech begins phase 1 trial for malaria vaccine

December 23, 2022 Medical Communications

BioNTech has announced the start of its new first-in-human phase 1 trial for BNT165b1, a candidate from its programme which …
News

Celltrion submits application for CT-P13 SC to FDA

December 23, 2022 Medical Communications

Celltrion has announced that it has finalised its submission of a biologics license application for the subcutaneous version of a …
News

COVID-19 antiviral treatment shown to speed up recovery in trial

December 23, 2022 Medical Communications

Molnupiravir, made by Merck, Sharp and Dohme (MSD), has been found to reduce the recovery time of COVID-19 patients, however …
News

Treatment for rare, paediatric growth hormone deficiency recommended by NICE for use on the NHS

December 22, 2022 Medical Communications

Walton Oaks, 22 December 2022 – Pfizer Ltd today announces that the National Institute for Health and Care Excellence (NICE) …
News
Press release

AstraZeneca shares two new drug approvals in the EU

December 22, 2022 Medical Communications

On Wednesday, AstraZeneca announced two drug approvals in the European Union (EU). The first being Imfinzi’s approval for the treatment …
News

Everest Medicines and licensing partner Pfizer receive FDA and EMA approval for ulcerative colitis drug

December 22, 2022 Medical Communications

Everest Medicines, a biopharmaceutical company, has announced that its licensing partner, Pfizer, has received acceptance from the FDA for a …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025